IBS-Smart: When Food Poisoning Explains Everything
A bout of food poisoning years ago can leave behind an autoimmune injury to the gut's pacemaker cells. That injury impairs motility permanently, and impaired motility is why the SIBO keeps coming back no matter how well you clear it.
The question it answers
Most IBS diagnoses are arrived at by exclusion. Everything else was ruled out, nothing was found, and the patient leaves with a label that describes their symptoms back to them and explains nothing.
They have usually also been told, somewhere along the way, that it is stress.
IBS-Smart asks a different question. It measures two antibodies — anti-CdtB and anti-vinculin — and a positive result identifies a specific cause: an autoimmune process, triggered by a past gut infection, that damaged the cells controlling motility.
That turns a diagnosis of exclusion into a diagnosis of mechanism. For the patient it is often the first explanation anyone has offered them in a decade. For you it changes the treatment plan, because the thing you are managing is no longer bacterial overgrowth — it is the motility injury that keeps producing it.
From food poisoning to vinculin
The chain is worth knowing in full, because it is what you will explain to the patient.
1. The infection. Campylobacter, Salmonella, Shigella or certain E. coli — ordinary acute gastroenteritis. Bad food, travel, a restaurant, a stomach bug that laid them out for a few days and then passed.
2. The toxin. Those organisms produce cytolethal distending toxin B, or CdtB.
3. The antibody. The immune system responds to CdtB, as it should, and makes antibodies against it.
4. The cross-reaction. CdtB structurally resembles vinculin, a protein in the interstitial cells of Cajal — the pacemaker cells that generate the gut's rhythm and drive the migrating motor complex. The anti-CdtB antibodies cross-react with the patient's own vinculin.
5. The damage. The MMC is the housekeeping wave that sweeps the small intestine clear between meals. Damage the cells that drive it and the sweeping stops working properly.
6. The consequence. Bacteria that should be swept distally stay in the small bowel. That is SIBO, and it is now being generated continuously by a motility defect rather than by a one-off event.
The infection may have been eight years ago and entirely forgotten. The antibodies and the injury are what remained.
What a positive changes
Three things, and the first one is the big one.
Relapse stops being a failure. If motility is impaired, clearing the overgrowth was always going to be temporary. The bacteria were a symptom of the defect, not the defect. A practitioner who knows this plans for maintenance from the start instead of treating the third recurrence as evidence that something went wrong.
Motility support moves to the centre of the plan. It is not an add-on at the end of a protocol. In a patient whose MMC is damaged, it is the part that determines whether anything holds. Meal spacing matters for the same reason — the migrating motor complex only runs between meals, so a patient grazing all day never lets it run at all.
The expectations conversation changes. You are not telling this patient you will fix them in twelve weeks. You are telling them they have an identifiable injury, that it explains a decade of being told it was stress, and that it is manageable rather than curable. Most of them find that an enormous relief. Being believed, with a mechanism attached, is worth a great deal to someone who has been dismissed repeatedly.
What a negative means
Less than people assume, and this is where the test gets over-read.
The antibodies are specific rather than highly sensitive. A positive is meaningful. A negative does not exclude post-infectious IBS, and it certainly does not exclude a motility problem — it tells you this particular antibody-mediated mechanism was not demonstrated.
A patient can have impaired motility from adhesions, surgery, medication, neurological disease, hypothyroidism or diabetes, and none of those produce anti-vinculin antibodies.
Two further limits worth holding:
It was developed for diarrhoea-predominant IBS. The validation work centres on IBS-D. Applying it confidently to a constipation-predominant patient is extending it past where the evidence sits.
It does not diagnose IBS and it does not exclude anything serious. It identifies a mechanism within a diagnosis you have already reached by other means. Inflammatory bowel disease, coeliac disease and malignancy still have to be excluded the ordinary way — calprotectin, serology, referral where there are alarm features. A positive IBS-Smart in a patient losing weight does not explain the weight loss.
Use it to confirm a suspicion. Do not use it to rule out.
Where it sits
Four tests, four different questions. Running them without knowing which question each answers is how people end up with a folder of results and no plan.
Test | The question |
IBS-Smart | Is there an autoimmune motility injury behind this? |
SIBO breath test | Is there overgrowth in the small bowel right now? |
GI Map | What is the picture in the colon, and is digestion working? |
Calprotectin | Is this inflammatory bowel disease rather than IBS? |
The pairing that earns its keep is IBS-Smart plus a breath test. The breath test tells you what is happening today; IBS-Smart tells you whether it will keep happening. One guides the clearing protocol, the other tells you what comes after it.
And calprotectin comes first in anyone where IBD is on the table at all. Treating Crohn's as post-infectious IBS costs the patient time they cannot get back.
Where to start
Ask the question nobody asks. Did this start after a stomach bug, a holiday, or a bad meal? Patients rarely volunteer it because nobody has ever suggested the two things were connected, and it was years ago.
Exclude the serious things first. Calprotectin, coeliac serology, referral where there are alarm features. IBS-Smart is not a safety net.
Test where the history fits — diarrhoea-predominant, onset traceable to an infection, repeated SIBO relapse.
If positive, build the plan around motility. Clearing protocol, then motility support and meal spacing as the ongoing work, not the afterthought.
Set the expectation honestly. Manageable, not curable. Say it at the start rather than at the third relapse.
The GHT Academy Gut Guide covers IBS-Smart and SIBO interpretation biomarker by biomarker, with SIBO subtypes, root cause analysis and complete protocols — specific supplements, dosing and timelines, including the motility piece that decides whether any of it holds. It is the reference I built for my own team.
Comments